Description
| 100 U/mL 1×10 mL | 1 Vial |
Humulin 30/70 Vial stands as a beacon of scientific achievement and patient-centric design in diabetes care. At its core lies a meticulously formulated mixture of human insulin, with 30% taking on the role of rapid-acting insulin and the remaining 70% being intermediate-acting. This carefully calibrated balance ensures that patients benefit from both immediate and prolonged effects.
Upon administration, the rapid-acting component springs into action, targeting sudden spikes in blood glucose, especially post meals. This swift response ensures that patients can go about their daily routines without the looming fear of sudden high sugar levels. On the other hand, the intermediate-acting insulin provides a steady, consistent release, offering a blanket of protection that spans the day. This dual-action approach is akin to having a vigilant guard that actively reacts to immediate threats while ensuring long-term security.
Furthermore, the fusion of these two types of insulin in a single vial not only simplifies the dosing regimen but also minimizes the chances of unpredictable glucose fluctuations. By catering to both immediate and long-term needs, Humulin 30/70 Vial ensures that managing diabetes is not just about reacting to the present but also preparing for the future, offering peace of mind around the clock.
